Leveraging real-world data to meet payers’ needsPayers are becoming savvier in accepting real-world data. Certara’s Lee Stern and Shawn Bates discuss the challenges and Share XLeveraging real-world data to meet payers’ needshttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/real-world-data-meet-payers-needs-certara/
Time for a new model in patient accessMig Sleeper, vice president, Global Pricing for Astellas Pharma Europe, explains why we must rethink how value is Share XTime for a new model in patient accesshttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/astellas-new-model-patient-access/
Time to take patient engagement to the next levelPatient engagement in pharma is evolving, with some companies doing it better than others. Envision Pharma Group’s Dawn Share XTime to take patient engagement to the next levelhttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/envision-pharma-patient-engagement/
Patients want to be heard. Is pharma listening?A common theme heard from the advocacy groups AXON works with is “Nothing for us without us,” says Share XPatients want to be heard. Is pharma listening?https://deep-dive.pharmaphorum.com/magazine/patients-partnerships/patients-want-to-be-heard-is-pharma-listening/
Three views on technology improving clinical trial efficiencyMarie Emms, vice president of site and patient participation at Syneos Health, tells us technology helped increase patient Share XThree views on technology improving clinical trial efficiencyhttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/syneos-technology-improving-clinical-trial/
Emerging from the shadow of COVID-19We now have a unique opportunity to re-discover what matters most to patients, says Alnylam’s Kasha Witkos. In Share XEmerging from the shadow of COVID-19https://deep-dive.pharmaphorum.com/magazine/patients-partnerships/biotech-alnylam-shadow-of-covid-19/
